Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin M. Slawin currently holds 324,982 shares of BELLICUM PHARMACEUTICALS, INC (BLCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin M. Slawin has been a net seller of BLCM stock. They have purchased $0 and sold $4.1M worth of shares.
Kevin M. Slawin's most recent insider trade was on Dec 15, 2016, when they sold 30,000 shares at $15.45 per share.
Kevin M. Slawin serves as Executive at BELLICUM PHARMACEUTICALS, INC (BLCM). They have executed 40 insider transactions totaling $4.1M over their tenure at the company.
Kevin M. Slawin holds the position of Executive at BELLICUM PHARMACEUTICALS, INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Kevin M. Slawin has shown a selling trading pattern, with $0 in total purchases and $4.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin M. Slawin was on Aug 15, 2016, when they sold $657.6K worth of BLCM shares. This transaction involved 34,127 shares at $19.27 per share.
Kevin M. Slawin currently owns 324,982 shares of BELLICUM PHARMACEUTICALS, INC (BLCM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin M. Slawin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin M. Slawin has 40 Form 4 filings on record as an insider at BELLICUM PHARMACEUTICALS, INC.
Set alerts for Kevin M. Slawin and 40,000+ other insiders.